Unidoc Health Corp. (UDOC.CN)
CAD 0.46
(-1.09%)
CAD 0.46
(-1.09%)
| Breakdown | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
| Revenue | - | - | - | - |
| Cost of Revenue | 68.26 Thousand | 64.22 Thousand | 15.24 Thousand | - |
| Gross Profit | -68.26 Thousand | -64.22 Thousand | -15.24 Thousand | - |
| Operating Expenses | 2.13 Million | 1.35 Million | 3 Million | 237.32 Thousand |
| Selling, General and Administrative Expenses | 2.11 Million | 1.1 Million | 2.63 Million | 237.32 Thousand |
| Research and Development Expenses | 17.65 Thousand | 12.09 Thousand | 353.01 Thousand | - |
| Other Expenses | - | 35 Thousand | - | - |
| Cost and Expenses | 2.2 Million | 1.35 Million | 3 Million | 237.32 Thousand |
| Operating Income | -2.2 Million | -1.31 Million | -3 Million | -237.32 Thousand |
| Interest Expense | 8675.00 | 9080.00 | 1771.00 | - |
| Income Tax Expense | -1.00 | 44.08 Thousand | 1771.00 | -206.29 Thousand |
| Earnings before Tax | -2.25 Million | -1.35 Million | -3 Million | -237.32 Thousand |
| Net Income | -2.25 Million | -1.35 Million | -3 Million | -237.32 Thousand |
| Earnings Per Share Basic | -0.04 | -0.06 | -0.14 | -0.00 |
| Earnings Per Share Diluted | -0.04 | -0.06 | -0.14 | -0.00 |
| Weighted Average Shares Outstanding | 50.34 Million | 21.86 Million | 21.86 Million | 84.9 Million |
| Weighted Average Shares Outstanding (Diluted) | 50.34 Million | 21.86 Million | 21.86 Million | 84.9 Million |
| Gross Margin | - | - | - | - |
| EBIT Margin | - | - | - | - |
| Profit Margin | - | - | - | - |
| EBITDA | -2.18 Million | -1.25 Million | -2.98 Million | -237.32 Thousand |
| Earnings Before Tax Margin | - | - | - | - |
| Breakdown | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 | 2023 Q1 |
|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - |
| Cost of Revenue | 8898.00 | 83.00 | 68.26 Thousand | 27 Thousand | 21.9 Thousand | 19.26 Thousand |
| Gross Profit | -8898.00 | -83.00 | -68.26 Thousand | -27 Thousand | -21.9 Thousand | -19.26 Thousand |
| Operating Expenses | 1.89 Million | 726.29 Thousand | 2.13 Million | 316.14 Thousand | 464.06 Thousand | 710.75 Thousand |
| Selling, General and Administrative Expenses | 1.86 Million | 708.64 Thousand | - | 316.14 Thousand | 373.63 Thousand | 653.32 Thousand |
| Research and Development Expenses | - | 17.65 Thousand | - | - | - | - |
| Other Expenses | 32.2 Thousand | - | - | - | - | - |
| Cost and Expenses | 1.89 Million | 726.37 Thousand | 2.2 Million | 343.15 Thousand | 464.06 Thousand | 710.75 Thousand |
| Operating Income | -1.89 Million | -726.38 Thousand | -2.2 Million | -343.15 Thousand | -464.06 Thousand | -710.75 Thousand |
| Interest Expense | 1475.00 | 1781.00 | 8675.00 | 2076.00 | 2369.00 | 2449.00 |
| Income Tax Expense | -1.89 Million | -3.00 | -1.00 | 4.00 | 2369.00 | 2449.00 |
| Earnings before Tax | -1.9 Million | -787.03 Thousand | -2.25 Million | -342.53 Thousand | -467.6 Thousand | -706.35 Thousand |
| Net Income | -1.9 Million | -787.03 Thousand | -2.25 Million | -342.53 Thousand | -467.6 Thousand | -706.35 Thousand |
| Earnings Per Share Basic | -0.05 | -0.01 | - | -0.01 | -0.02 | -0.03 |
| Earnings Per Share Diluted | -0.05 | -0.01 | - | -0.01 | -0.02 | -0.03 |
| Weighted Average Shares Outstanding | 35.06 Million | 57.37 Million | 50.34 Million | 27.34 Million | 23.62 Million | 22.29 Million |
| Weighted Average Shares Outstanding (Diluted) | 35.06 Million | 57.37 Million | 50.34 Million | 27.34 Million | 23.62 Million | 22.29 Million |
| Gross Margin | - | - | - | - | - | - |
| EBIT Margin | - | - | - | - | - | - |
| Profit Margin | - | - | - | - | - | - |
| EBITDA | -1.88 Million | -726.3 Thousand | - | -316.14 Thousand | -442.15 Thousand | -691.48 Thousand |
| Earnings Before Tax Margin | - | - | - | - | - | - |
TBLA
ULTHF
SKGR
025980
SFFFF
CTM